# OnCo record xuanzhu-biopharmaceutical (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/xuanzhu-biopharmaceutical/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "xuanzhu-biopharmaceutical" ;
  schema:name "Xuanzhu Biopharmaceutical"@en ;
  schema:alternateName "Xuanzhu Biopharmaceutical Co., Ltd."@en ;
  schema:description "Xuanzhu Biopharmaceutical is a China-based biotechnology company running 3 late-stage cancer trials of XZP-3287 and XZP-5955 in HR-positive / HER2-negative breast cancer and non-small-cell lung cancer."@en ;
  schema:url <https://onco.cc/companies/xuanzhu-biopharmaceutical/>, <https://www.xuanzhubio.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.xuanzhubio.com>, <https://clinicaltrials.gov/search?lead=Xuanzhu%20Biopharmaceutical%20Co.%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/nsclc/> ;
  onco:drugs <https://onco.cc/drugs/xzp-3287/> ;
  onco:trials <https://onco.cc/trials/nct05257395/>, <https://onco.cc/trials/nct04996121/> .